CMS proposed a rule to streamline the prior authorization process and expand health information access; a scathing report urged the FDA to consider restructuring and potentially dividing the agency; the Institute for Healthcare Improvement (IHI) and American Medical Association (AMA) are coleading the Rise to Health Coalition.
Under a new rule proposed by CMS, the agency will establish policies to make the prior authorization process more efficient and transparent, according to a CMS press release. Certain payers will also be required to implement an electronic prior authorization process, shorten time frames to respond to requests, and set standards to enable data exchange from one payer to another when a patient changes payers or has concurrent coverage. These requirements would generally apply to Medicare Advantage organizations, state Medicaid and Children’s Health Insurance Program (CHIP) agencies, Medicaid managed care plans, CHIP managed care entities, and Qualified Health Plan issuers on the federally facilitated exchanges. CMS estimates these streamlined processes would save physician practices and hospitals over $15 billion in a decade. AHIP has shown support of the new interoperability rule, which is available for review and comments until March 13, 2023.
A scathing report of the FDA by the Reagan-Udall Foundation was conducted in the wake of the infant formula crisis this year, and it urges the FDA to consider restructuring and potentially divide the agency so oversight of the food system gets more attention. As reported by The Washington Post, the task force’s first suggestion was to create separate food and drug administrations within HHS, requiring approval from Congress. Acknowledging the severity of this suggestion, the task force’s smaller suggestions included separating the food and drug arms but keeping them within a single agency, and creating a new deputy commissioner position with authority for overseeing food systems.
The Institute for Healthcare Improvement (IHI) announced the launch of a new national coalition on health equity co-ed by the American Medical Association (AMA) on Tuesday, Modern Healthcare reported. The Rise to Health Coalition will bring together hundreds of health systems, companies, and organizations to develop a cohesive approach to more equitable patient care and remove areas of inequity and bias. The coalition will also include individual providers, insurance companies, professional societies, and pharmaceutical, research, and biotech organizations to share solutions and take collective action.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More